Partial V(D)J recombination activity leads to Omenn syndrome. 1998

A Villa, and S Santagata, and F Bozzi, and S Giliani, and A Frattini, and L Imberti, and L B Gatta, and H D Ochs, and K Schwarz, and L D Notarangelo, and P Vezzoni, and E Spanopoulou
Department of Human Genome and Multifactorial Disease, Istituto di Tecnologie Biomediche Avanzate, Consiglio Nazionale delle Ricerche, Segrate (Milano) Italy.

Genomic rearrangement of the antigen receptor loci is initiated by the two lymphoid-specific proteins Rag-1 and Rag-2. Null mutations in either of the two proteins abrogate initiation of V(D)J recombination and cause severe combined immunodeficiency with complete absence of mature B and T lymphocytes. We report here that patients with Omenn syndrome, a severe immunodeficiency characterized by the presence of activated, anergic, oligoclonal T cells, hypereosinophilia, and high IgE levels, bear missense mutations in either the Rag-1 or Rag-2 genes that result in partial activity of the two proteins. Two of the amino acid substitutions map within the Rag-1 homeodomain and decrease DNA binding activity, while three others lower the efficiency of Rag-1/Rag-2 interaction. These findings provide evidence to indicate that the immunodeficiency manifested in patients with Omenn syndrome arises from mutations that decrease the efficiency of V(D)J recombination.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D004802 Eosinophilia Abnormal increase of EOSINOPHILS in the blood, tissues or organs. Eosinophilia, Tropical,Hypereosinophilia,Tropical Eosinophilia,Hypereosinophilias,Tropical Eosinophilias
D005260 Female Females

Related Publications

A Villa, and S Santagata, and F Bozzi, and S Giliani, and A Frattini, and L Imberti, and L B Gatta, and H D Ochs, and K Schwarz, and L D Notarangelo, and P Vezzoni, and E Spanopoulou
December 2011, Current opinion in allergy and clinical immunology,
A Villa, and S Santagata, and F Bozzi, and S Giliani, and A Frattini, and L Imberti, and L B Gatta, and H D Ochs, and K Schwarz, and L D Notarangelo, and P Vezzoni, and E Spanopoulou
May 2024, Science immunology,
A Villa, and S Santagata, and F Bozzi, and S Giliani, and A Frattini, and L Imberti, and L B Gatta, and H D Ochs, and K Schwarz, and L D Notarangelo, and P Vezzoni, and E Spanopoulou
August 2004, Immunological reviews,
A Villa, and S Santagata, and F Bozzi, and S Giliani, and A Frattini, and L Imberti, and L B Gatta, and H D Ochs, and K Schwarz, and L D Notarangelo, and P Vezzoni, and E Spanopoulou
November 1999, Current biology : CB,
A Villa, and S Santagata, and F Bozzi, and S Giliani, and A Frattini, and L Imberti, and L B Gatta, and H D Ochs, and K Schwarz, and L D Notarangelo, and P Vezzoni, and E Spanopoulou
January 2009, Advances in experimental medicine and biology,
A Villa, and S Santagata, and F Bozzi, and S Giliani, and A Frattini, and L Imberti, and L B Gatta, and H D Ochs, and K Schwarz, and L D Notarangelo, and P Vezzoni, and E Spanopoulou
January 2009, Advances in experimental medicine and biology,
A Villa, and S Santagata, and F Bozzi, and S Giliani, and A Frattini, and L Imberti, and L B Gatta, and H D Ochs, and K Schwarz, and L D Notarangelo, and P Vezzoni, and E Spanopoulou
March 2000, The Journal of biological chemistry,
A Villa, and S Santagata, and F Bozzi, and S Giliani, and A Frattini, and L Imberti, and L B Gatta, and H D Ochs, and K Schwarz, and L D Notarangelo, and P Vezzoni, and E Spanopoulou
January 1996, Advances in immunology,
A Villa, and S Santagata, and F Bozzi, and S Giliani, and A Frattini, and L Imberti, and L B Gatta, and H D Ochs, and K Schwarz, and L D Notarangelo, and P Vezzoni, and E Spanopoulou
June 2010, Nature reviews. Immunology,
A Villa, and S Santagata, and F Bozzi, and S Giliani, and A Frattini, and L Imberti, and L B Gatta, and H D Ochs, and K Schwarz, and L D Notarangelo, and P Vezzoni, and E Spanopoulou
July 2000, Nucleic acids research,
Copied contents to your clipboard!